Matinas BioPharma Holdings Inc (NYSEAMERICAN:MTNB) shares saw unusually-high trading volume on Friday . Approximately 4,908,119 shares were traded during mid-day trading, an increase of 304% from the previous session’s volume of 1,214,606 shares.The stock last traded at $1.30 and had previously closed at $1.20.

Separately, Roth Capital initiated coverage on Matinas BioPharma in a research report on Monday, February 11th. They issued a “buy” rating and a $4.75 price objective for the company.

Several institutional investors have recently bought and sold shares of MTNB. Renaissance Technologies LLC grew its position in shares of Matinas BioPharma by 325.6% during the 3rd quarter. Renaissance Technologies LLC now owns 134,900 shares of the company’s stock worth $124,000 after buying an additional 103,200 shares during the period. Virtu Financial LLC acquired a new position in shares of Matinas BioPharma during the 4th quarter worth about $39,000. IFP Advisors Inc grew its position in shares of Matinas BioPharma by 222.0% during the 4th quarter. IFP Advisors Inc now owns 1,775,000 shares of the company’s stock worth $1,083,000 after buying an additional 1,223,828 shares during the period. BlackRock Inc. grew its position in shares of Matinas BioPharma by 147.1% during the 4th quarter. BlackRock Inc. now owns 290,589 shares of the company’s stock worth $173,000 after buying an additional 173,005 shares during the period. Finally, Private Advisor Group LLC grew its position in shares of Matinas BioPharma by 100.4% during the 4th quarter. Private Advisor Group LLC now owns 49,850 shares of the company’s stock worth $30,000 after buying an additional 24,978 shares during the period.

TRADEMARK VIOLATION WARNING: “Matinas BioPharma (MTNB) Sees Strong Trading Volume” was originally published by Watch List News and is the sole property of of Watch List News. If you are accessing this report on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The correct version of this report can be read at https://www.watchlistnews.com/matinas-biopharma-mtnb-sees-strong-trading-volume/2897187.html.

Matinas BioPharma Company Profile (NYSEAMERICAN:MTNB)

Matinas BioPharma Holdings, Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. The company enables the delivery of life-changing medicines using its lipid nano-crystal (LNC) platform technology. Its LNC delivery technology platform utilizes lipid nano-crystals which can encapsulate small molecules, oligonucleotides, vaccines, peptides, proteins and other medicines potentially making them safer, more tolerable, less toxic, and orally bioavailable.

Further Reading: Stock Selection – What is cash flow?

Receive News & Ratings for Matinas BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Matinas BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.